Detalhe da pesquisa
1.
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
Proc Natl Acad Sci U S A
; 120(10): e2214561120, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853940
2.
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Age Ageing
; 51(5)2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595256
3.
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1.
Plant Cell Rep
; 41(4): 1013-1023, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178612
4.
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.
J Antimicrob Chemother
; 73(7): 1940-1948, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635527
5.
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.
Retrovirology
; 11: 44, 2014 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24909946
6.
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.
Nat Commun
; 15(1): 1051, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316751
7.
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
Nat Commun
; 15(1): 2349, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514609
8.
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions.
J Transl Med
; 11: 48, 2013 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23433486
9.
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.
Mol Oncol
; 17(4): 686-694, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495129
10.
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Vaccine
; 41(35): 5072-5078, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460353
11.
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
iScience
; 26(4): 106457, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999095
12.
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
NPJ Vaccines
; 8(1): 51, 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024469
13.
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.
iScience
; 26(7): 107224, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502366
14.
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Front Immunol
; 14: 1291972, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124756
15.
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.
iScience
; 26(3): 106126, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748086
16.
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype.
Retrovirology
; 9: 15, 2012 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22333046
17.
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.
Biomedicines
; 10(9)2022 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140273
18.
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.
Front Microbiol
; 13: 763039, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35401460
19.
Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.
Sci Rep
; 12(1): 14772, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042275
20.
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.
Front Immunol
; 13: 860215, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35572570